KEYTRUDA 25 mg/mL concentrate for solution for infusion, Olaparib, Olaparib
POINT
Phase 2 small_molecule active
Quick answer
KEYTRUDA 25 mg/mL concentrate for solution for infusion, Olaparib, Olaparib for Adult patients affected by recurrent/metastatic, platinum resistant nasopharyngeal cancer is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- Adult patients affected by recurrent/metastatic, platinum resistant nasopharyngeal cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active